Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
May 20, 2021
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
Justin Loke, Richard Buka, Charles Craddock
Frontiers in Oncology
|
May 3, 2021
Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia
Justin Loke, Hrushikesh Vyas, Charles Craddock
British Journal of Haematology
|
December 12, 2019
The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
Justin Loke, Ram Malladi, Paul Moss, et al.
British Journal of Haematology
|
April 11, 2024
Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
Francesca A M Kinsella, Maria A L Maroto, Justin Loke, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
November 23, 2007
Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients
David Hughes, John Hafferty, Lee Fulton, et al.
Blood Advances
|
February 13, 2018
C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia
Justin Loke, Paulynn Suyin Chin, Peter Keane, et al.
British Journal of Haematology
|
September 7, 2021
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy
Justin Loke, Marlen Metzner, Rebecca Boucher, et al.
British Journal of Haematology
|
September 10, 2025
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)
Andrew Clark, Hazel Clouston, Kanchan Rao, et al.
Cell Reports
|
May 25, 2017
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
Justin Loke, Salam A Assi, Maria Rosaria Imperato, et al.
Blood
|
February 25, 2015
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
Francis Mussai, Sharon Egan, Joseph Higginbotham-Jones, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
May 20, 2021
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
Justin Loke, Richard Buka, Charles Craddock
Frontiers in Oncology
|
May 3, 2021
Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia
Justin Loke, Hrushikesh Vyas, Charles Craddock
British Journal of Haematology
|
December 12, 2019
The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
Justin Loke, Ram Malladi, Paul Moss, et al.
British Journal of Haematology
|
April 11, 2024
Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
Francesca A M Kinsella, Maria A L Maroto, Justin Loke, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
November 23, 2007
Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients
David Hughes, John Hafferty, Lee Fulton, et al.
Blood Advances
|
February 13, 2018
C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia
Justin Loke, Paulynn Suyin Chin, Peter Keane, et al.
British Journal of Haematology
|
September 7, 2021
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy
Justin Loke, Marlen Metzner, Rebecca Boucher, et al.
British Journal of Haematology
|
September 10, 2025
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)
Andrew Clark, Hazel Clouston, Kanchan Rao, et al.
Cell Reports
|
May 25, 2017
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
Justin Loke, Salam A Assi, Maria Rosaria Imperato, et al.
Blood
|
February 25, 2015
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
Francis Mussai, Sharon Egan, Joseph Higginbotham-Jones, et al.
Page
of 3